Heritage Bio Labs
Research Library
Explore 411 articles about peptides, research compounds and related topics, with links to the original studies.
Find articles
Matching articles
Showing 109–120 of 134 articles · Explore study findings
- Explore study findings
What the 2026 FDA Appraisal Found About Semax and Stroke
Semax is a synthetic seven-amino-acid peptide derived in part from a region of adrenocorticotropic hormone. It has been studied in relation to cerebral ischemia, a loss of adequate blood flow to brain tissue.
Semax2 sources (2018, 2026)
- Explore study findings
What the Interim Compounding Policy Actually Covers for Semax
Semax is a synthetic seven-amino-acid peptide. In 2026, FDA and HHS documents discussed specific Semax-related bulk substances. These sources explain a regulatory context, not a finding that Semax improves memory or recovery.
Semax3 sources (2026)
- Explore study findings
What the FDA's Geref records say about its former indications
Sermorelin is a synthetic 29-residue fragment of human growth hormone–releasing hormone, with an amidated end. The history of Geref, a U.S. sermorelin acetate product, shows how a diagnostic approval and a treatment approval can address separate questions.
Sermorelin2 sources (1996, 2013)
- Explore study findings
What human liver fractions revealed about SLU-PP-332 breakdown
SLU-PP-332 is a small synthetic compound with a different chemical structure from a peptide. It activates a group of proteins called estrogen-related receptors. In 2026, two laboratories examined what happened to the compound when exposed to enzymes prepared from human liver tissue.
SLU-PP-3323 sources (2023, 2026)
- Explore study findings
Why SLU-PP-915 results belong to a different compound
SLU-PP-332 is a synthetic small molecule outside that class. It acts on estrogen-related receptors, which help regulate genes involved in energy metabolism. A recent animal study compared it with another small molecule called SLU-PP-915 and examined which effects were shared.
SLU-PP-3321 source (2025)
- Explore study findings
Which part of an exercise response appeared in mouse muscle?
SLU-PP-332 is a synthetic small molecule that activates estrogen-related receptors, a family that helps regulate genes involved in muscle metabolism. An older study asked whether one receptor subtype was important for the muscle and endurance responses observed in mice.
SLU-PP-3321 source (2023)
- Explore study findings
What donated skin and volunteer observations each contribute
SNAP-8 is the name used for acetyl octapeptide-3, a chemically modified cosmetic peptide with eight amino acids. An older paper studied a serum that the authors identified as containing acetyl octapeptide-3 along with other ingredients.
SNAP-82 sources (2020, 2022)
- Explore study findings
Why hydration, skin thickness and fine lines are different outcomes
SNAP-8 is acetyl octapeptide-3, a modified eight-amino-acid cosmetic ingredient. An older single-center study evaluated a cosmetic patch containing this peptide with several other ingredients. It measured fine lines, hydration and features of deeper skin tissue as separate outcomes.
SNAP-81 source (2019)
- Explore study findings
What the survodutide cardiovascular trial was designed to count
Survodutide is an investigational peptide that activates the glucagon and GLP-1 receptors. The SYNCHRONIZE cardiovascular study was designed to examine whether cardiovascular events occurred at different rates in adults with excess body weight assigned to survodutide or placebo.
Survodutide2 sources (2023, 2026)
- Explore study findings
Why the two LIVERAGE studies use different liver outcomes
Survodutide is an investigational peptide that acts on the glucagon and GLP-1 receptors. The LIVERAGE registry records describe two trials that ask different questions about liver disease at different stages of scarring.
Survodutide3 sources (2024, 2026)
- Explore study findings
What the Chinese and Japanese trials tell us about who was studied
Survodutide is an investigational peptide that acts at glucagon and GLP-1 receptors. Two 2026 design reports described how researchers set up randomized weight-management trials in China and Japan, including who could enroll and when outcomes would be measured.
Survodutide2 sources (2026)
- Explore study findings
What an MRI showed about liver fat in SYNCHRONIZE-MASLD
Survodutide is an investigational glucagon and GLP-1 receptor agonist peptide. A phase 3 study reported in 2026 asked whether it changed liver fat and body weight in adults with obesity and at-risk metabolic dysfunction-associated steatotic liver disease, or MASLD.
Survodutide2 sources (2024, 2026)
Browse by product
- A4 Amyloid Beta6 articles
- ACE-0316 articles
- ACE-0836 articles
- Adipotide6 articles
- AICAR6 articles
- AOD-96046 articles
- ARA-2906 articles
- BPC-1576 articles
- BPC-157 / TB-5006 articles
- Cagrilintide7 articles
- CJC-1295 (No DAC) / GHRP-26 articles
- CJC-1295 (No DAC) / GHRP-66 articles
- CJC-1295 (No DAC) / Ipamorelin6 articles
- CJC-1295 No DAC6 articles
- CJC-1295 With DAC6 articles
- DSIP6 articles
- Epitalon6 articles
- Follistatin 3156 articles
- Follistatin 3446 articles
- Fragment 176-1916 articles
- GHK-Cu6 articles
- GHRP-26 articles
- GHRP-66 articles
- GLOW 2 Blend6 articles
- GLOW Blend6 articles
- GLP-1 SEMA6 articles
- GLP-2 TIRZ6 articles
- Glutathione6 articles
- HCG6 articles
- Hexarelin6 articles
- Human Relaxin-26 articles
- IGF-1 DES 1,36 articles
- IGF-1 Human6 articles
- IGF-2 LR36 articles
- IGF-DES 1,36 articles
- IGF-LR36 articles
- Ipamorelin6 articles
- Kisspeptin-106 articles
- KLOW Blend6 articles
- KPV6 articles
- Lipopeptide6 articles
- Liraglutide6 articles
- Melanotan II5 articles
- MGF6 articles
- MOTS-C6 articles
- MSC Exosomes6 articles
- Myostatin6 articles
- Myostatin HMP (GDF8)6 articles
- Oxytocin7 articles
- PEG-MGF6 articles
- Pinealon6 articles
- PT-1416 articles
- RETA / IGF-1 LR36 articles
- RETA GLP-36 articles
- Selank6 articles
- SEMA / IGF-1 LR36 articles
- Semax6 articles
- Sermorelin6 articles
- SLU-PP-3326 articles
- SNAP-86 articles
- Survodutide7 articles
- TB-5006 articles
- Tesamorelin6 articles
- Thymosin Alpha-16 articles
- TIRZ / IGF-1 LR36 articles
- TIRZ GLP-26 articles
- Trevogrumab6 articles
- Triptorelin GnRH6 articles
